Cargando…

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer

BACKGROUND AND PURPOSE: To determine if suppression of active bone marrow, as defined on FDG PETCT, is seen in on-treatment imaging of anal cancer patients receiving concurrent chemoradiation. METHODS AND MATERIALS: Scans from 26 patients participating in the ART trial (full title: Anal squamous cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Maxwell, Muirhead, Rebecca, Jacobs, Clare, Cooke, Rosie, Chu, Kwun-Ye, Van den Heuvel, Frank, Ng, Stasya, Virdee, Pradeep, Strauss, Victoria, Hawkins, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077746/ https://www.ncbi.nlm.nih.gov/pubmed/31506182 http://dx.doi.org/10.1016/j.radonc.2019.08.016

Ejemplares similares

Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma
por: Bluemke, Emma, et al.
Publicado: (2020)

Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2015)

Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT)
por: Durrant, Lisa, et al.
Publicado: (2016)

Variable uterine uptake of FDG in adenomyosis during concurrent chemoradiation therapy for cervical cancer
por: Yu, Jeong Il, et al.
Publicado: (2011)

18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation
por: David, John M., et al.
Publicado: (2019)

Concurrent Chemoradiation in Anal Cancer Patients Delivered with Bone Marrow-Sparing IMRT: Final Results of a Prospective Phase II Trial
por: Arcadipane, Francesca, et al.
Publicado: (2021)

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)
por: Casadei-Gardini, Andrea, et al.
Publicado: (2019)

Long-Term Disease Control After locoregional Pelvic Chemoradiation in Patients with Advanced Anal Squamous Cell Carcinoma
por: Grave, Athénaïs, et al.
Publicado: (2022)

Concurrent Chemoradiation for Vaginal Cancer
por: Miyamoto, David T., et al.
Publicado: (2013)

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum]
por: Casadei-Gardini, A, et al.
Publicado: (2019)

Concurrent FDG Avid Nasopharyngeal Lesion and Generalized Lymphadenopathy on PET-CT Imaging Is Indicative of Lymphoma in Patients with HIV Infection
por: Liu, Yiyan
Publicado: (2012)

Long-Term Outcomes of Chemoradiation for Anal Cancer Patients
por: Kim, Hun Jin, et al.
Publicado: (2013)

Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation
por: Kumar, T, et al.
Publicado: (2019)

Impact of abdominal compression on setup error and image matching during radical abdominal radiotherapy
por: Chu, Kwun-Ye, et al.
Publicado: (2019)

Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes
por: Cooke, Rosie, et al.
Publicado: (2020)

Cardiac Magnetic Resonance for Evaluating Catheter Related FDG Avidity
por: Jeong, Daniel, et al.
Publicado: (2016)

FDG avid solitary pulmonary nodule mimicking lung cancer
por: Alduraibi, Alaa Khalid
Publicado: (2022)

Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT
por: Reinholdt, Kasper Basse, et al.
Publicado: (2022)

The Role of (18) F-FDG PET/CT in Assessing Therapy Response in Cervix Cancer after Concurrent Chemoradiation Therapy
por: Choi, Jiyoun, et al.
Publicado: (2013)

A prospective comparative study between concurrent chemoradiation with brachytherapy boost with concurrent chemoradiation alone in locally advanced cancer esophagus
por: Tudu, Rajanigandha
Publicado: (2020)

Clinical Impact of Pelvic Lymph Node Status in Locally Advanced Cervical Cancer Patients Treated by Concurrent Chemoradiation Therapy
por: Katanyoo, Kanyarat, et al.
Publicado: (2021)

Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis
por: Koerber, Stefan Alexander, et al.
Publicado: (2014)

Brachytherapy boost after chemoradiation in anal cancer: a systematic review
por: Frakulli, Rezarta, et al.
Publicado: (2018)

Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma
por: Shakir, Rebecca, et al.
Publicado: (2020)

Intra-operative use of PET probe for localization of FDG avid lesions
por: Molina, M.A., et al.
Publicado: (2009)

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer
por: Warren, Samantha, et al.
Publicado: (2017)

Preoperative Nodal (18)F-FDG Avidity Rather than Primary Tumor Avidity Determines the Prognosis of Patients with Advanced Gastric Cancer
por: Kwon, Hyun Woo, et al.
Publicado: (2018)

Penile Mondor's disease in a patient treated with radical chemoradiation for anal cancer
por: Pittaka, Maria, et al.
Publicado: (2017)

FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT
por: Nguyen, Xuan Canh, et al.
Publicado: (2015)

Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using (18)F-FDG PET
por: Yoon, Joon-Kee, et al.
Publicado: (2019)

Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation
por: Garcia, Brandon, et al.
Publicado: (2016)

Malignancy Risk in (18)F-FDG-Avid Thyroid Incidentalomas: Controversies and Limitations
por: Bukhari, Khulood, et al.
Publicado: (2021)

Multiple Subcutaneous (18)F-FDG-avid Granulomas Due to Enoxaparin Injection
por: Erol Fenercioğlu, Özge, et al.
Publicado: (2022)

Increased FluoroDeoxyGlucose (FDG) Avidity Following COVID-19 Vaccination
por: Nassar, Mo’ath, et al.
Publicado: (2022)

Incorporating (18)FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation
por: Franco, Pierfrancesco, et al.
Publicado: (2017)

Achalasia Combined with Esophageal Cancer Treated by Concurrent Chemoradiation Therapy
por: Park, Jun Chul, et al.
Publicado: (2009)

Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
por: Shi, Feiya, et al.
Publicado: (2022)

Potential Pitfall in the Assessment of Lung Cancer with FDG-PET/CT: Talc Pleurodesis Causes Intrathoracic Nodal FDG Avidity
por: Wang, Yingbing, et al.
Publicado: (2013)

A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial
por: Tangjitgamol, Siriwan, et al.
Publicado: (2019)

Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
por: Thind, Govin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cgkhgbovnft26ul5ssmp39md7s